Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A multi-ingredient, over-the-counter analgesic and antipyretic combination used for the temporary relief of mild to moderate pain (such as headache, muscle aches, dental pain, and fever). It contains three pharmacologically active small molecules: acetaminophen (analgesic and antipyretic), salicylamide (NSAID with analgesic and anti-inflammatory properties), and caffeine (a central nervous system stimulant that enhances the analgesic effect and absorption of acetaminophen and salicylamide). The combination offers broad-spectrum relief by addressing different aspects of pain and is formulated to achieve a synergistic effect, providing greater efficacy than the individual components alone[3][4][5][7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on acetaminophen + salicylamide + caffeine.